Moderna hopes to offer updated COVID-19 booster for latest variant this fall
Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant.
Firefighter of 18 years in east King County fired due to state's COVID-19 vaccine mandate
Ten firefighters in east King County are now out of a job-- they were let go from Eastside Fire & Rescue on Monday because they are not vaccinated against COVID-19.
Several Eastside firefighters released over COVID-19 vaccine mandate
Several firefighters with Eastside Fire and Rescue will be out of a job Monday after not getting the COVID-19 vaccine.
WA Board of Health votes 'no' on including COVID vaccine in child immunizations
The Washington Board of Health voted to not include the COVID-19 vaccine as a required immunization for kids going to school.
Can families still gather for spring break, Easter with new COVID variant? WA health officials weigh in
Across the country, COVID restrictions are easing, but at the same time, Washington is seeing a new surge in cases.
COVID-19 vaccine second booster: Who needs one and when?
The Food and Drug Administration authorized a second COVID-19 booster for many Americans. Here's a look at who is eligible and when to get it.
UW Medicine says benefit of FDA-approved 2nd booster shot is 'very marginal'
The FDA has authorized a second COVID-19 booster shot for people ages 50 and up, but researchers at UW Medicine believe the benefits are limited.
Moderna says its low-dose COVID shots work for kids under 6; will seek federal approval
Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.
Comfort dog helps calm children getting COVID shots
Getting a COVID-19 shot can be scary, especially for many children in our community.
UW Medicine seeks participants for Novavax booster study
UW Medicine seeks participants for a trial on Novavax's COVID-19 booster shot.
Pfizer seeks approval for 4th COVID-19 booster dose for seniors
Pfizer is expected to request authorization for a fourth COVID-19 vaccine dose for seniors in a move to provide extra protection to the over-65 population that has been hit hardest by the pandemic.
Panel opts against new vaccine requirement for Washington schools
A state advisory group has decided against recommending a COVID-19 vaccine requirement for students in K-12 schools.
Exercise after COVID-19 vaccine may increase antibodies, study finds
The study demonstrates that 90 minutes of exercise after immunization of the COVID-19 vaccine increases antibody response several weeks later.
Pfizer shot offers nearly no protection against infection in 5- to 11-year-olds
Pfizer's COVID-19 vaccine is effective at preventing hospitalization in children 5 to 11 but offers virtually no protection against infection, even just a month after full immunization.
Seattle, King County to end vaccine verification policy March 1
King County announced that it will end the county's vaccine verification policy to enter restaurants, bars, theaters and gyms on March 1.
Seattle to close last COVID-19 vaccine clinic Thursday, citing high vaccinations
After four months of administering COVID-19 vaccines in West Seattle, the city's vaccine clinic at Neighborhood House closed down Saturday.
Seattle, King County to end vaccine verification policy at restaurants, gyms, theaters March 1
King County announced that it will end the county's vaccine verification policy to enter restaurants, bars, theaters and gyms on March 1.
FDA postpones advisory meeting on COVID-19 vaccines for kids under 5
U.S. health regulators have delayed a public meeting to review a COVID-19 vaccine for children under 5.
Pfizer asks FDA for emergency approval of COVID-19 vaccine for kids under 5
Children 6 months to 5 years old are one step closer to receiving the Pfizer COVID-19 vaccine after the company officially submitted the two-dose regimen to the FDA for emergency approval.
Moderna's COVID-19 vaccine gets full FDA approval
Moderna's COVID-19 vaccine called “Spikevax” has been given full approval from the U.S. Food and Drug Administration.